199 related articles for article (PubMed ID: 18398274)
1. Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism.
Turhan S; Sezer S; Erden G; Guctekin A; Ucar F; Ginis Z; Ozturk O; Bingol S
Ann Saudi Med; 2008; 28(2):96-101. PubMed ID: 18398274
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
Luboshitzky R; Aviv A; Herer P; Lavie L
Thyroid; 2002 May; 12(5):421-5. PubMed ID: 12097204
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine.
Adamarczuk-Janczyszyn M; Zdrojowy-Wełna A; Rogala N; Zatońska K; Bednarek-Tupikowska G
Adv Clin Exp Med; 2016; 25(3):457-63. PubMed ID: 27629733
[TBL] [Abstract][Full Text] [Related]
4. Association Between Cardiovascular Risk Factors and Serum Thyrotropin Concentration Among Healthy Chinese Subjects and Subjects with Unsuspected Subclinical Hypothyroidism.
Wu J; Tao Y; Gu H; Sui J
Clin Lab; 2016; 62(5):807-14. PubMed ID: 27349005
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum lipoprotein(a) in subclinical hypothyroidism.
Kung AW; Pang RW; Janus ED
Clin Endocrinol (Oxf); 1995 Oct; 43(4):445-9. PubMed ID: 7586619
[TBL] [Abstract][Full Text] [Related]
6. A study on serum homocysteine and oxidized LDL as markers of cardiovascular risk in patients with overt hypothyroidism.
Kumar Singh N; Suri A; Kumari M; Kaushik P
Horm Mol Biol Clin Investig; 2022 Sep; 43(3):329-335. PubMed ID: 35179003
[TBL] [Abstract][Full Text] [Related]
7. The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism.
Serter R; Demirbas B; Korukluoglu B; Culha C; Cakal E; Aral Y
J Endocrinol Invest; 2004 Nov; 27(10):897-903. PubMed ID: 15762035
[TBL] [Abstract][Full Text] [Related]
8. Effect of the normalization of TSH and free T4 on lipid profile in a pediatric population with primary hypothyroidism.
Rivera-Hernández A; Rojas-Martínez R; Mendoza-Zubieta V; Balcázar-Hernández L
Andes Pediatr; 2021 Feb; 92(1):59-66. PubMed ID: 34106184
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?
Duntas LH; Wartofsky L
Thyroid; 2007 Nov; 17(11):1075-84. PubMed ID: 17900236
[TBL] [Abstract][Full Text] [Related]
10. Serum lipids, tHcy, hs-CRP, MDA and PON-1 levels in SCH and overt hypothyroidism: effect of treatment.
Singh S; Dey Sarkar P
Acta Biomed; 2014 Aug; 85(2):127-34. PubMed ID: 25245648
[TBL] [Abstract][Full Text] [Related]
11. Thyroid dysfunction and serum lipids: a community-based study.
Walsh JP; Bremner AP; Bulsara MK; O'leary P; Leedman PJ; Feddema P; Michelangeli V
Clin Endocrinol (Oxf); 2005 Dec; 63(6):670-5. PubMed ID: 16343102
[TBL] [Abstract][Full Text] [Related]
12. Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism.
Tanaci N; Ertugrul DT; Sahin M; Yucel M; Olcay I; Demirag NG; Gursoy A
Endocrine; 2006 Jun; 29(3):451-6. PubMed ID: 16943584
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues.
Staub JJ; Althaus BU; Engler H; Ryff AS; Trabucco P; Marquardt K; Burckhardt D; Girard J; Weintraub BD
Am J Med; 1992 Jun; 92(6):631-42. PubMed ID: 1605145
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
15. A Study of Lipid Profile in Patients with Subclinical Hypothyroidism.
S S; Mb V
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443331
[TBL] [Abstract][Full Text] [Related]
16. LDL in patients with subclinical hypothyroidism shows increased lipid peroxidation.
Zha K; Zuo C; Wang A; Zhang B; Zhang Y; Wang B; Wang Y; Zhao J; Gao L; Xu C
Lipids Health Dis; 2015 Aug; 14():95. PubMed ID: 26302822
[TBL] [Abstract][Full Text] [Related]
17. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
18. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
19. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects.
Bakker SJ; ter Maaten JC; Popp-Snijders C; Slaets JP; Heine RJ; Gans RO
J Clin Endocrinol Metab; 2001 Mar; 86(3):1206-11. PubMed ID: 11238510
[TBL] [Abstract][Full Text] [Related]
20. Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.
Unal E; Akın A; Yıldırım R; Demir V; Yildiz İ; Haspolat YK
J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):144-149. PubMed ID: 28008862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
